<HashMap><database>GEO</database><scores/><additional><omics_type>Other</omics_type><species>Homo sapiens</species><gds_type>Other</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298780</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Glycation DNA immunoprecipitation sequencing (GlyDIP-seq) for detecting epigenetic effects unique to diabetes [DIP-Seq]</name><description>DNA glycation, a non-enzymatic modification triggered by reactive metabolites such as methylglyoxal (MG), has been implicated in various metabolic and neurological disorders. However, its genome-wide distribution and biological consequences in the developing brain remain largely unexplored. To address this gap, we developed a novel method, GlyDIP-seq, which enables high-resolution profiling of glycation-derived DNA lesions (specifically N²-carboxyethyl-2'-deoxyguanosine, CEdG) across the genome.</description><dates><publication>2026/05/18</publication></dates><accession>GSE298780</accession><cross_references><GSM>GSM9023159</GSM><GSM>GSM9023167</GSM><GSM>GSM9023166</GSM><GSM>GSM9023169</GSM><GSM>GSM9023158</GSM><GSM>GSM9023168</GSM><GSM>GSM9023157</GSM><GSM>GSM9023174</GSM><GSM>GSM9023163</GSM><GSM>GSM9023173</GSM><GSM>GSM9023162</GSM><GSM>GSM9023165</GSM><GSM>GSM9023164</GSM><GSM>GSM9023170</GSM><GSM>GSM9023172</GSM><GSM>GSM9023161</GSM><GSM>GSM9023171</GSM><GSM>GSM9023160</GSM><GPL>34281</GPL><GSE>298780</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>